Cyclophosphamide After Sibling-donor allogeneic stem-cell Transplantation (CAST) in patients with acute leukaemia and myelodysplasia (CHERE)

Project Member(s): De Abreu Lourenco, R.

Funding or Partner Organisation: Medical Research Future Fund (Medical Research Future Fund- Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity)
Medical Research Future Fund (Medical Research Future Fund- Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity)

Start year: 2018

Summary: A randomised study comparing cyclosporin and methotrexate to cyclosporin and post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis.

FOR Codes: Applied Economics, Evaluation of Health Outcomes, Cancer and Related Disorders, Development studies, Policy and administration, Clinical health, Evaluation of health and support services

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.